BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Diabetes. May 15, 2026; 17(5): 118754
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.118754
Table 3 Interventional strategies for pancreatic macrophage metabolic memory
Intervention strategy
Representative agents/methods
Mechanism of action
Specificity for memory erasure
Evidence type
Ref.
Lifestyle interventionAerobic exerciseActivates SIRT1 pathway, promotes macrophage M2 polarization, downregulates TNF-α/IL-6, upregulates IL-10High
Rationale: > 8 weeks via H3K4me3/H3K27ac epigenetic remodeling; pancreatic macrophage direct evidence
Preclinical + clinical[90,91]
Improves pancreatic macrophage metabolic reprogramming, enhances PKB2-mediated insulin signalingObese mice (n = 10/group): Reduces HOMA-IR, upregulates PBMC SIRT1
H3K27ac, inhibits HDAC3, modulates epigenetic memoryObese humans (n = 89): Endurance exercise enhances insulin sensitivity
Natural productsResveratrol, curcuminResveratrol: Activates adenosine monophosphate - AMPK/SIRT1/Nrf2, inhibits NF-κB, enhances IL-10 promoter H3K27ac; regulates macrophage polarization (concentration-dependent)Moderate
Rationale: 2 weeks; histone modification; pancreatic macrophage direct evidence
Preclinical + clinical[92,93]
Curcumin: Blocks TLR4/MyD88/NF-κB, inhibits NLRP3 inflammasome, reverses IL-6 promoter DNA methylation; alleviates pancreatic β-cell oxidative stressCells (3 independent experiments): Resveratrol reduces LPS-induced NO/TNF-α, curcumin inhibits IL-1β
Human trial (n = 40): 1 g/day resveratrol increases SHBG, improves metabolism
Epigenetic modulatorsHDACi, miR-10a mimicsHDAC inhibitors: Inhibit HDAC1/2/3, reduce H3K27me3, activate Nrf2, enhance IL-10 expressionExtremely high
Rationale: 4-8 weeks; reverses obesity-induced epigenetic abnormalities; pancreatic macrophage direct evidence
Preclinical + clinical[94]
miR-10a mimics: Promotes pancreatic macrophage OXPHOS, increases acetyl-CoA/H3K18ac, inhibits HDAC3, modulates metabolic memoryMice: Improves glucose/insulin resistance, reduces macrophage infiltration
Lymphoma patients: MS-275 lowers TNF-α/IL-6
Human pancreatic macrophages: SAHA upregulates IL-10
miRNA-based interventionmiR-10a mimics, miR-146a mimics, miR-155 antagonistsmiR-10a: Regulates metabolic reprogramming, enhances H3K18ac, blocks inflammatory memoryExtremely high
Rationale: 6-8 weeks; reverses epigenetic abnormalities; pancreatic macrophage direct evidence
Preclinical[91,95]
miR-146a: Targets HDAC2-PI3K axis, inhibits M1 polarizationMice: MiR-10a reduces M1/M2 ratio, miR-146a improves insulin sensitivity
miR-155 antagonists: Rescues PDX1, associated with pancreatic β-cell functionCells: MiR-146a upregulates IL-10, miR-155 antagonists inhibit TNF-α
OtherDMIMevalonate: Induces innate immune memory via inflammatory gene H3K27ac/H3K4me3Moderate
Rationale: > 3 weeks; reverses partial inflammatory memory; pancreatic macrophage direct evidence
Preclinical[91]
DMI: Enriches TNF/IL-6 promoter H3K4me3, reduces H3K9me3, regulates metabolic memory, inhibits inflammatory responses in pancreatic macrophagesCells: Mevalonate enhances secondary inflammatory response, DMI inhibits LPS-induced TNF-α
Animal experiment: DMI improves obesity-related inflammation


Write to the Help Desk